In an article published in the April issue of The Journal of Nuclear Medicine, researchers at Stanford University in California provide a template for assessing new positron emission tomography (PET) radiotracers that can ...
Apr 7, 2017
0
8
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for bone scintigraphy (scans to identify bone metastases) in patients with prostate or breast cancer. This is the ...
Apr 6, 2017
0
1
Researchers have used positron emission tomography (PET) to successfully identify genetic cell mutations that can cause lung cancer. The research, published in the featured article of the April 2017 issue of The Journal of ...
Apr 3, 2017
0
0
The featured clinical investigation article of the March 2017 issue of the Journal of Nuclear Medicine demonstrates that the PET radiotracer fluciclovine (fluorine-18; F-18) can help guide and monitor targeted treatment for ...
Mar 6, 2017
0
159
In the featured article of the March 2017 issue of The Journal of Nuclear Medicine, researchers demonstrate that a new positron emission tomography (PET) radiotracer, gallium-68 (Ga-68)-pentixafor, can quickly and non-invasively ...
Mar 1, 2017
0
358
A study published in the February issue of The Journal of Nuclear Medicine demonstrates the potential of extending peptide receptor radionuclide therapy targeting the somatostatin receptor to other types of malignancies beyond ...
Feb 6, 2017
0
51
In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers document the first-in-human application of a new imaging agent to help find prostate cancer in both early and advanced stages ...
Feb 1, 2017
0
5
In an article published in the January 2017 issue of The Journal of Nuclear Medicine, researchers assert that exposure to medical radiation does not increase a person's risk of getting cancer. The long-held belief that even ...
Jan 9, 2017
0
2
A German multicenter study, initiated by the German Society of Nuclear Medicine, demonstrates that lutetium-177 (Lu-177)-labeled PSMA-617 is a promising new therapeutic agent for radioligand therapy (RLT) of patients with ...
Jan 5, 2017
0
0
In nuclear medicine, the goal is to keep radiation exposure at a minimum, while obtaining quality images. Optimal dosing for individual patients can be difficult to determine. That's where 3D-printed organ models of varying ...
Dec 5, 2016
0
51
